Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC)

Journal of Controlled Release

Volumn 74, Issue 1-3, 2001, Pages 335-340

  Rudge, S ^a   Peterson, C ^a   Vessely, C ^a   Koda, J ^a   Stevens, S ^a   Catterall, L ^a  

^a FeRx Incorporated   (United States)

Author keywords

Anticancer drugs; Magnetically targeted carriers; MTC; Tumor targeting

Indexed keywords

9 AC; 9AC; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DOXORUBICIN; DRUG CARRIER; METHOTREXATE; MITOMYCIN C; UNCLASSIFIED DRUG; VERAPAMIL;

CANCER CHEMOTHERAPY; CELL CULTURE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DESORPTION; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TARGETING; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAGNET; MAGNETISM; PARTICLE SIZE; PLASMA; PREDICTION; PRIORITY JOURNAL; THERMODYNAMICS;

ADSORPTION; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG CARRIERS; HUMANS; INJECTIONS, INTRA-ARTERIAL; MAGNETICS; MICE; NONLINEAR DYNAMICS; THERMODYNAMICS; TUMOR CELLS, CULTURED;

EID: 0035816190     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00344-3     Document Type: Article

References (2)

1. Preparation, characterization, and performance of magnetic iron-carbon composite microparticles for chemotherapy
2. Distribution of adriamycin in cancer patients: Tissue uptakes, plasma concentration and i.v. and hepatic i.a. administration